Cargando…
Reply to the letter to the editor “Azithromycin, treatment in COVID-19”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816577/ https://www.ncbi.nlm.nih.gov/pubmed/33476734 http://dx.doi.org/10.1016/j.ijantimicag.2021.106279 |
| _version_ | 1783638471342030848 |
|---|---|
| author | Manafi, Navid Ghiasvand, Fereshteh |
| author_facet | Manafi, Navid Ghiasvand, Fereshteh |
| author_sort | Manafi, Navid |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7816577 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd and International Society of Antimicrobial Chemotherapy. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78165772021-01-21 Reply to the letter to the editor “Azithromycin, treatment in COVID-19” Manafi, Navid Ghiasvand, Fereshteh Int J Antimicrob Agents Article Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021-03 2021-01-19 /pmc/articles/PMC7816577/ /pubmed/33476734 http://dx.doi.org/10.1016/j.ijantimicag.2021.106279 Text en © 2021 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Manafi, Navid Ghiasvand, Fereshteh Reply to the letter to the editor “Azithromycin, treatment in COVID-19” |
| title | Reply to the letter to the editor “Azithromycin, treatment in COVID-19” |
| title_full | Reply to the letter to the editor “Azithromycin, treatment in COVID-19” |
| title_fullStr | Reply to the letter to the editor “Azithromycin, treatment in COVID-19” |
| title_full_unstemmed | Reply to the letter to the editor “Azithromycin, treatment in COVID-19” |
| title_short | Reply to the letter to the editor “Azithromycin, treatment in COVID-19” |
| title_sort | reply to the letter to the editor “azithromycin, treatment in covid-19” |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816577/ https://www.ncbi.nlm.nih.gov/pubmed/33476734 http://dx.doi.org/10.1016/j.ijantimicag.2021.106279 |
| work_keys_str_mv | AT manafinavid replytothelettertotheeditorazithromycintreatmentincovid19 AT ghiasvandfereshteh replytothelettertotheeditorazithromycintreatmentincovid19 |